JapanStake
Services · Fiscal year end May 31

Pharmarise Holdings Corporation

2796

ファーマライズホールディングス株式会社

FIGI BBG000JJSN972796.T2796 JPCorp. no. 5011201003645

Latest half-year results

First half · fiscal year to 2026-05 · filed 2026-01-09

For the first half of the fiscal year to 2026-05: Revenue ¥33.6 billion (+10.0% YoY), Ordinary income ¥0.3 billion (+1031.0% YoY), Net income ¥0.1 billion.

This periodYear on year
Revenue¥33.6bn+10.0%
Ordinary profit¥328m+1031.0%
Net profit to owners¥111m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/2796/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-05-31
Revenue
¥69.5bn
Net income
¥114m
ROE
1.7%
Equity ratio
20.3%
Dividend / share
¥14
Employees
2,031
Revenue · ¥bn
FY2022: ¥51.6bn 51.6 FY2022FY2023: ¥52.0bn 52 FY2023FY2024: ¥54.5bn 54.5 FY2024FY2025: ¥63.5bn 63.5 FY2025FY2026: ¥69.5bn 69.5 FY2026
Net income · ¥m
FY2022: ¥447m 447 FY2022FY2023: ¥333m 333 FY2023FY2024: −¥351m -351 FY2024FY2025: −¥367m -367 FY2025FY2026: ¥114m 114 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-05-31¥69.5bn¥0.1bn¥32.7bn¥6.9bn1.7%¥10.01¥3.3bn
2025-05-31¥63.5bn−¥0.4bn¥31.9bn¥6.9bn-5.3%¥-32.48¥1.3bn
2024-05-31¥54.5bn−¥0.4bn¥29.5bn¥7.4bn-5.1%¥-33.41¥2.7bn
2023-05-31¥52.0bn¥0.3bn¥23.4bn¥7.0bn5.1%¥35.45¥2.5bn
2022-05-31¥51.6bn¥0.4bn¥23.7bn¥6.7bn7.2%¥47.99¥0.7bn

Indicators

Computed by us from filings · fiscal year to 2026-05-31
MetricValuePercentile among listed companies
ROE, %1.79.9
Ordinary margin0.010312.5
Equity ratio, %20.37.4
Revenue growth0.094567.9
Net income growth1.310688.2
Operating cash flow / assets0.100373.3
Policy-uncertainty measure0.46 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 3.3% held by other listed companies.

Results wording balance: +0.56. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥14.6bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥73m, 2.2% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/2796/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-08-20: see filing 上記の評価の結果、代表取締役 社長 [氏名省略]は、当事業年度末日時点における当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Dispensing Pharmacy, Cosmetic Drug and Convenience Store, Custody of Medical Documents, Medical Mall, Other. /v1/companies/2796/segments
Latest voting result: 2026-08-28 · 剰余金処分の件 · passed. /v1/companies/2796/voting

Ownership changes

All companies →
  • 2025-10-07
    Increase+1.81pt

    individual filer raised holdings in Pharmarise Holdings Corporation (2796) to 35.09% from 33.28%.

    01020304050
  • 2025-10-07
    Threshold

    Holdings of individual filer in Pharmarise Holdings Corporation (2796) moved above 33.4% (33.28% -> 35.09%).

    01020304050
  • 2023-12-05
    Amendment−20.59pt

    individual filer filed a correction to a 5% report on Pharmarise Holdings Corporation (2796).

  • 2023-11-30
    Decrease−20.59pt

    individual filer reduced holdings in Pharmarise Holdings Corporation (2796) to 33.28% from 53.87%.

    0255075100
  • 2023-11-30
    Threshold

    Holdings of individual filer in Pharmarise Holdings Corporation (2796) moved below 33.4% (53.87% -> 33.28%).

    0255075100
  • 2023-11-30
    Threshold

    Holdings of individual filer in Pharmarise Holdings Corporation (2796) moved below 50% (53.87% -> 33.28%).

    0255075100
  • 2023-11-30
    Amendment−20.59pt

    individual filer filed a correction to a 5% report on Pharmarise Holdings Corporation (2796).

  • 2023-11-28
    Amendment0.00pt

    individual filer filed a correction to a 5% report on Pharmarise Holdings Corporation (2796).

  • 2023-11-22
    New 5% stake

    SUZUKEN CO.,LTD. disclosed a 19.46% stake in Pharmarise Holdings Corporation (2796), crossing the 5% reporting threshold.

    01020304050
  • 2023-11-22
    Threshold

    Holdings of SUZUKEN CO.,LTD. in Pharmarise Holdings Corporation (2796) moved above 10% (new -> 19.46%).

    01020304050

Trades by 5% holders

From the 60-day trade tables in 5% reports
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2023-09-29 – 2025-10-0100.00pt——
株式会社スズケン2023-11-21 – 2023-11-21+2,346,600+19.46pt¥758¥758–758
individual filer2023-11-13 – 2023-11-21-2,346,600−18.83pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/2796/trades.

5% filings

Large shareholding reports on 2796
FiledFilerStakeChangeStated purpose
2025-10-07individual filer35.09%+1.81ptmanagement participation
2023-12-05individual filer33.28%−20.59ptmanagement participation
2023-11-30individual filer33.28%−20.59ptmanagement participation
2023-11-30individual filer33.28%−20.59ptmanagement participation
2023-11-28individual filer53.87%0.00ptmanagement participation
2023-11-22SUZUKEN CO.,LTD.19.46%——
2023-11-20individual filer53.87%+0.01ptmanagement participation
2023-11-20individual filer53.87%0.00ptmanagement participation
2023-11-17individual filer53.87%0.00ptmanagement participation
2023-10-13individual filer53.87%+1.08ptmanagement participation

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
1

Held by: VITAL KSK HOLDINGS,INC. 3151

Purposes, all holdings and mutual flags via /v1/companies/2796/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-05-31
ShareholderSharesRatio
individual holder3,015,00026.20%
individual holder2,309,60020.10%
individual holder513,1704.50%
individual holder426,6903.70%
ファーマライズ従業員持株会415,8003.60%
individual holder396,0003.40%
individual holder396,0003.40%
individual holder119,0001.00%
individual holder106,5350.90%
明治安田生命保険相互会社100,0000.90%

Get this as JSON

GET /v1/companies/2796
GET /v1/companies/2796/financials
GET /v1/companies/2796/details
GET /v1/companies/2796/segments
GET /v1/companies/2796/voting
GET /v1/companies/2796/tender-offers
GET /v1/companies/2796/indicators
GET /v1/companies/2796/earnings-releases
GET /v1/events?ticker=2796
GET /v1/companies/2796/trades         
GET /v1/companies/2796/cross-holdings 
GET /v1/companies/2796/brief          

Plans from $9 a month · Documentation